Citation:Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al 1990

From Cancer Guidelines Wiki

Citation


Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990 Feb 22;322(8):494-500 Available from: http://www.ncbi.nlm.nih.gov/pubmed/2405271.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al 1990What is the clinical benefit of adjuvant whole brain radiotherapy following resection or stereotactic radiosurgery to the brain metastasis(es)?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al 1990 2What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al 1990 3What is the role of stereotactic radiosurgery in the treatment of brain metastases?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al 1990 4What is the clinical benefit of resection of brain metastasis?Dr Stephen Barnettcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of adjuvant whole brain radiotherapy following resection or stereotactic radiosurgery to the brain metastasis(es)|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of adjuvant whole brain radiotherapy following resection or stereotactic radiosurgery to the brain metastasis(es)</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of stereotactic radiosurgery in the treatment of brain metastases?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of stereotactic radiosurgery in the treatment of brain metastases?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the clinical benefit of resection of brain metastasis?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of resection of brain metastasis?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Recommended surgical approach to brain metastases in patients with advanced melanoma
  2. Summary of recommendations and practice points: Treatment approaches to brain metastases for patients with melanoma
  3. What is the clinical benefit of resection of brain metastasis?
  4. What is the role of stereotactic radiosurgery in the treatment of brain metastases?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Patchell_RA,_Tibbs_PA,_Walsh_JW,_Dempsey_RJ,_Maruyama_Y,_Kryscio_RJ,_et_al_1990&oldid=20416"